Ormat Tech SEC Filings

Insider activity summary: Director Stanley Stern exercised 1,210 stock appreciation rights (SARs) with an exercise price of $76.87, based on SARs that expire November 6, 2025. The exercise used the market value on the exercise date of $94.83 to determine payout, resulting in issuance of 229 common shares and a cash settlement for the remaining economic value equivalent to 981 shares. On the same day, 229 shares were sold at $94.83, and an additional 400 shares were sold on September 30, 2025 at $95.98. After these transactions, Mr. Stern beneficially owned 4,861 shares.

Form 144 notice for Ormat Technologies (ORA): The filing reports a proposed sale of 400 common shares through Morgan Stanley Smith Barney with an aggregate market value of $38,393.84, scheduled approximately on 09/30/2025. The filer states total shares outstanding of 60,723,470. The 400 shares were acquired as restricted stock on 05/08/2025 from the issuer and paid for on that date. The filing also lists two recent dispositions by the same person: 229 shares sold on 09/26/2025 for $21,716.60 and 876 shares sold on 08/27/2025 for $80,578.86. The notice includes the standard Rule 144 attestation that the seller is not aware of undisclosed material adverse information.

Form 144 notice for ORMAT TECHNOLOGIES, INC. (ORA) shows a proposed sale of 5,611 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $531,922.60, with an approximate sale date of 09/29/2025. The filing lists multiple underlying acquisitions: restricted stock grants on various dates in 2023, 2024 and 2025 totaling listed lots (e.g., 288, 313, 519, 393 shares) and a Stock Appreciation Rights award of 3,810 units on 09/29/2025 paid in cash. It also discloses a prior sale on 08/22/2025 of 692 shares for $65,442.44. Several standard signature and representation statements are included.

Form 144 notice for ORMAT TECHNOLOGIES, INC. (ORA) reports a proposed sale of 14,994 common shares on 09/29/2025 through Morgan Stanley Smith Barney LLC on the NYSE. The aggregate market value of the shares is listed as $1,420,153.71 and the issuer’s outstanding shares are shown as 60,723,470. The shares were acquired the same day as Stock Appreciation Rights from the issuer and payment is noted as cash. The filer reports no securities sold in the past three months and attests to lack of undisclosed material adverse information.

Assi Ginzburg, Chief Financial Officer of Ormat Technologies, Inc. (ORA) reported an open-market sale of 9,343 shares of the company’s common stock on 09/18/2025. The filing states these shares were sold in multiple transactions at a weighted average price of $93.31, with individual trade prices ranging from $93.30 to $93.375. After the reported disposals, the reporting person beneficially owns 24,482 shares. The Form 4 was signed by an attorney-in-fact and includes an undertaking to provide detailed trade-by-trade breakdowns to the company, securityholders, or the SEC staff upon request.

David Granot, a director of Ormat Technologies (ORA), exercised 1,210 Stock Appreciation Rights (SARs) on 08/21/2025. Upon exercise he delivered 1,011 shares back to the issuer to cover the exercise price and sold the remaining 199 shares in the open market the same day. The Form 4/A amends a prior Form 4 filed 08/25/2025 to correct an administrative error: the previously reported post-transaction beneficial ownership amounts were overstated by 838 shares and have been reduced accordingly. The SARs exercised had a grant price of $76.87 and expire on 11/06/2025.

Form 144 filed for ORA (Ormat Technologies, Inc.) reporting a proposed sale of common stock by an insider. The notice lists 9,343 shares offered for sale through Morgan Stanley Smith Barney LLC with an aggregate market value of $871,810.28 and indicates approximately 60,723,470 shares outstanding. The filing details that the securities were acquired mostly as restricted stock and performance shares on various dates from 2023 to 2025. The filer also reported a sale on 08/22/2025 of 7,066 shares generating $669,220.86 in gross proceeds. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.

Orm at Technologies insider sale disclosure: Director Stanley Stern sold 876 shares of ORA common stock in the open market on 08/27/2025 at a reported price of $91.985 per share. After the sale, the reporting person beneficially owned 5,261 shares, held directly. The Form 4 was filed by an attorney-in-fact (/s/ Jessica Woelfel) on 08/29/2025. The filing is a routine Section 16 disclosure of a single non-derivative disposition and does not include any derivatives, amendments, or additional transactions.

Form 144 for Ormat Technologies, Inc. (ORA) shows a proposed sale of 876 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $80,578.86 and an approximate sale date of 08/27/2025. The shares were acquired as restricted stock on 05/08/2025 from the issuer and paid for on that date. The filing notes 60,723,470 shares outstanding for the class. It also reports a prior sale by the same account: 547 shares sold on 06/20/2025 for gross proceeds of $46,791.58. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.